
|
full-time / combined |
|
Czech / English |
|
4 years |
|
oral |
|
until 31st October 2028 |
|
Pharmacy (100 %) |
Study program Pharmaceutical Technology fully employs recent scientific knowledge in the development and manufacturing of dosage forms, is based on the actual theoretical and application knowledge in formulation of dosage forms and drug delivery systems, and allows to acquire the study program aims and the required profile of the study program graduate.
Graduates in the doctoral program of Pharmaceutical Technology will have a complete and unique view on general and special methods of the formulation of dosage forms, their structure, physical and chemical properties, and the use of mathematical models targeted to optimize biopharmaceutical properties of the pharmaceutical preparations, including local and time profile of the drug release.
To acquire this profile, graduates need detailed knowledge about the properties of pharmaceutical excipients, particularly the polymer ones, the lipidic substances, surfactants and the other substances which can modify the drug release. Moreover, the knowledge of the methods of technological processing of these substances in production of dosage forms, including pharmaceutical nanotechnologies, the mathematical and statistical modelling of individual phases of formulation and manufacturing of pharmaceutical preparations and drug delivery systems is presented. The knowledge of the methods for evaluation of the final product properties and biopharmaceutical characteristics is expected, particularly for novel advanced delivery systems with modified drug release or targeted effect.
Oral exam from the knowledge of the general and special pharmaceutical technology.
English language exam for English language knowledge assessment (C1 at least).
The minimum admission limit is 20 points.
The Dean decides to accept the applicant(s) who have fulfilled the conditions of the admission procedure and, according to the number of points achieved, ranked in the order corresponding to the predetermined number of accepted applicants for the particular program.
The specific content of the doctoral study of each student is set by an individual study plan. It has to contain at least three exams from the following list:
Students who have not read basic pharmaceutical subjects during their Master´s degrees will find these subjects incorporated into their individual study plans.
The student may as well enroll subjects offered in other fields according to the specific focus of their work.
An exam in English is a part of the study programme. This exam is not counted as one of the compulsory exams mentioned above.
In accordance with the research project the student must demonstrate within the chosen field the ability to carry out experimental work independently, to continuously assess and process the results, and discuss them within the contemporary scientific publications.
The student is required to be a co-author of 2 publications in IF journals, and at least in one case the student must be the first author. It is also possible to publish only 1 publication with the candidate as the first author in a journal with IF above 5 and/or the first decile.
An inseparable part of the study requirements within the doctoral study programme is taking part in international internship with the duration of at least 3 months. The student is welcome to participate in international collaboration, e.g. taking part in an international project with results published or presented abroad, etc.
An integral part of the individual study plan is a continuous publication activity and presentation of the achieved results at scientific conferences in the Czech Republic as well as abroad.
It is possible for the students to take part in the master education (practical training).
During the state doctoral examination, the student is assigned a topic from the mentioned thematic areas according to the focus of the dissertation.
Skin Barrier Research Group
Group leader: prof. PharmDr. Kateřina Vávrová, Ph.D.
Group of Clinical and Molecular Pharmacotherapy
Group leader: prof. PharmDr. Petr Pávek, Ph.D.
Dosage Forms & Drug Delivery Systems Research Group
Group leader: doc. PharmDr. Barbora Vraníková, Ph.D.
Research Group of Mathematical Pharmacy
Group leader: doc. Dipl.-Math. Erik Jurjen Duintjer Tebbens, Ph.D.